Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. - sprookjes - yvandenbroek - TriplyDB

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

http://www.wikidata.org/entity/Q34111796

about

Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

P2860

Q35813247-3F64AA83-FAF1-45FC-81D4-7D00F1E1EA43

P2860

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

http://www.wikidata.org/entity/Q34111796

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@ast

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@en

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@nl

type

label

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@ast

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@en

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@nl

prefLabel

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@ast

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@en

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

@nl

P1433

Q34111796-78A591CA-885D-4A06-AF8F-4237134E9C97

P1476

Q34111796-9B91B759-FABD-4D40-9628-9C7566415D19

P2093

Q34111796-264AB8D4-B3DE-4C03-89B0-19B344395DA4

Q34111796-6087C2F0-DDAA-4326-8F0A-0089EDB783A6

Q34111796-7D966092-9D7F-4AAF-BBF7-655E5F99B31B

Q34111796-8ACEDC3A-626E-4B36-A6FB-4A34A3A8D0E7

Q34111796-8DE5FE06-89A6-482A-8613-CAAD1E0C5D8D

Q34111796-981EC0C2-B8A5-4E6F-8A8E-847C76C4BCF0

Q34111796-A15B8CB2-89CC-4E57-85FE-75C4CC09240C

Q34111796-A48F979E-2FAA-410B-AC9F-F596381144AA

Q34111796-A74E8771-94FC-46A2-98EF-C79BA985B310

Q34111796-AEA06C56-FC18-44B3-80FE-EBAC752B3D55

P2860

Q34111796-0727DA12-67B9-4F30-B6FD-0458EDB50FEF

Q34111796-07D7A47B-DBFC-4F36-84B5-A1374B8FB59C

Q34111796-110CA1A3-CCBC-4A62-9EF9-4F82C6446680

Q34111796-12AA8866-A84D-417F-8200-1758517CB0DB

Q34111796-21B4864E-A3AD-4841-8CC3-DD9D07C82FA5

Q34111796-33E04CC7-2E59-4913-99A2-94759A786085

Q34111796-3BAE5338-9045-4C5F-8C41-5619C255CEC4

Q34111796-4C1CD24D-B8AE-4BB6-B67E-D635774A3BED

Q34111796-4E0427C0-2808-4F97-B31F-992F9424CAC5

Q34111796-52DF32E1-5FB4-4D4D-82C7-B57DDFE1070A

P304

Q34111796-81CF889B-9999-48DF-9696-15E56FC73F0B

P31

Q34111796-BCFFA1BB-A1B3-4CEE-8EBA-834574828B73

P478

Q34111796-B1D6A370-C612-4A14-9D15-AA07E5A618F8

P50

Q34111796-9FD44C56-882B-4A05-ADE4-A4BAA1AE5D1D

P577

Q34111796-521E5B40-1A04-43F5-83D6-599C30E9B4BC

P698

Q34111796-C6EE4323-9022-45CE-941D-2EF36A5A2C8D

P921

Q34111796-C10009D3-3AD7-44F1-AFF2-E0E8D3733B13

P932

Q34111796-413A5BB2-E0C3-45BD-AFD7-C909CA1F3FBC

P1433

Cancer Immunity

P1476

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8

@en

P2093

Alexander Knuth

http://www.w3.org/2001/XMLSchema#string

Christoph Renner

http://www.w3.org/2001/XMLSchema#string

Eliane Fischer

http://www.w3.org/2001/XMLSchema#string

Gerd Ritter

http://www.w3.org/2001/XMLSchema#string

Joachim C Mertens

http://www.w3.org/2001/XMLSchema#string

Lloyd J Old

http://www.w3.org/2001/XMLSchema#string

Margarita Plesko

http://www.w3.org/2001/XMLSchema#string

Natalie Fadle

http://www.w3.org/2001/XMLSchema#string

Nicole Adrian

http://www.w3.org/2001/XMLSchema#string

Stefan Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils

An endotoxin-induced serum factor that causes necrosis of tumors

Inflammation and cancer

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

Leukocyte arrest during cytokine-dependent inflammation in vivo.

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor

Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation.

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19267427

http://www.w3.org/2001/XMLSchema#string

P921

P932

2935764

http://www.w3.org/2001/XMLSchema#string